NSE BSE
welcure drugs & pharmaceutical stock

WELCURE DRUGS & PHARMACEUTICAL Share Price

- - (%)
- NSE: WELCURE

WELCURE DRUGS & PHARMACEUTICAL Share Price Update

As of the latest trading session, WELCURE DRUGS & PHARMACEUTICAL share price is currently at 6.66, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 6.32 and 6.98. Over the past year, WELCURE DRUGS & PHARMACEUTICAL has achieved a return of 64.19 %. In the last month alone, the return has been 21.79 %. Read More...

WELCURE DRUGS & PHARMACEUTICAL Performance

Day Range

Low6.32 High6.98
6.66

52 Week Range

Low 3.20 High 6.98
6.66

WELCURE DRUGS & PHARMACEUTICAL Share Price

524661

WELCURE

img img img img
No Data Available

Open Price

6.98

Prev. Close

6.65

Volume (Shares)

123839.00

Total traded value

8.24

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

WELCURE DRUGS & PHARMACEUTICAL Fundamentals


(Standalone)

Market Cap (Cr) 9.00
PE Ratio (TTM) 0.00
Book Value / Share 1.04
Beta 0.69
ROE 0.62%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.02

WELCURE DRUGS & PHARMACEUTICAL Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.10
Net Profit -0.10
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.09
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit -0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.05
Net Profit 0.17
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.12
EBITDA 0.17
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.27
Net Profit -0.18
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.13
EBITDA -0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit 0.10
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.08
EBITDA 0.10
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.11
Operating Expense 0.08
Net Profit 0.02
Net Profit Margin (%) 18.18
Earnings Per Share (EPS) 0.02
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit 0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.05
EBITDA 0.06
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.09
Net Profit -0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2008 (Values in Cr)
Book Value / Share 5.64
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.42
EBITDA Margin -3.61
Particulars MAR 2007 (Values in Cr)
Book Value / Share 7.23
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.41
EBITDA Margin -0.40
Particulars MAR 2006 (Values in Cr)
Book Value / Share 7.94
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.21
EBITDA Margin -5.76
Particulars MAR 2005 (Values in Cr)
Book Value / Share 9.57
ROE % 3.45
ROCE % 6.33
Total Debt to Total Equity 0.15
EBITDA Margin 4.42
Particulars MAR 2004 (Values in Cr)
Book Value / Share 9.47
ROE % 2.79
ROCE % 5.32
Total Debt to Total Equity 0.24
EBITDA Margin 3.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.13
ROE % 0.62
ROCE % 0.62
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.08
ROE % 0.16
ROCE % 0.16
Total Debt to Total Equity 0.00
EBITDA Margin 18.18
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.06
ROE % 0.98
ROCE % 0.98
Total Debt to Total Equity 0.00
EBITDA Margin 46.15
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -12.50
Particulars MAR 2019 (Values in Cr)
Book Value / Share 0.02
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 1.52
Total Liabilities 1.52
Total Equity 1.51
Share Outstanding 13512100
Price to Book Ratio 3.56
Return on Assets (%) 6.65
Return on Capital (%) 6.71
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.09
Total Liabilities 0.09
Total Equity 0.09
Share Outstanding 13512100
Price to Book Ratio 122.13
Return on Assets (%) 24.35
Return on Capital (%) 25.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 0.07
Total Liabilities 0.07
Total Equity 0.06
Share Outstanding 13512100
Price to Book Ratio 31.33
Return on Assets (%) 75.52
Return on Capital (%) 79.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.02
Total Liabilities 0.02
Total Equity 0.01
Share Outstanding 12118600
Price to Book Ratio 40.00
Return on Assets (%) -38.21
Return on Capital (%) -65.73
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 0.02
Total Liabilities 0.02
Total Equity 0.02
Share Outstanding 12118557
Price to Book Ratio 26.50
Return on Assets (%) 13.00
Return on Capital (%) 16.36
Particulars MAR 2023 (Values in Cr)
Net Income 0.10
Cash from Operations 0.10
Cash from Investing 1.32
Cash from Financing -1.49
Net change in Cash -0.06
Free Cash Flow 0.10
Particulars MAR 2022 (Values in Cr)
Net Income 0.02
Cash from Operations 0.01
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow 0.01
Particulars MAR 2021 (Values in Cr)
Net Income 0.05
Cash from Operations 0.04
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.04
Free Cash Flow 0.04
Particulars MAR 2020 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2019 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 116.40 12.72 1.26 1219.15 77.65 / 148.95
CIPLA LTD 1505.80 28.56 4.55 121596.06 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 203.65 0.00 2.07 599.36 136.00 / 219.05
GLAXOSMITHKLINE PHARMA LT 2559.65 66.04 24.39 43362.02 1376.50 / 2759.00
SANOFI INDIA LIMITED 6432.15 26.11 14.59 14813.24 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
WELCURE DRUGS & PHARMACEUTICAL 6.65 0.00 6.37 8.98 3.20 / 6.65
AMRUTAJAN HEALTH LTD 761.05 48.91 7.62 2200.24 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6864.45 114.79 24.10 17161.13 3650.05 / 7550.00
BLISS GVS PHARMA LTD 116.40 16.01 1.23 1219.15 77.65 / 148.95
ABBOTT INDIA LIMITED 27823.05 49.22 15.98 59123.98 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 6.20
  • 26 Days 5.40
  • 10 Days 5.90
  • 50 Days 5.20
  • 12 Days 5.80
  • 100 Days 5.10
  • 20 Days 5.70
  • 200 Days 4.00
6.65
PIVOT
First Resistance 6.65
Second Resistance 6.65
Third Resistance 6.65
First Support 6.65
Second Support 6.65
Third Support 6.65
RSI 77.62
MACD 0.38
Commodity Channel Index (CCI) 195.04
ADX 31.85
Williams % R 0.00

Over 1 Month

down

21.79

Over 3 Months

down

34.34

Over 6 Months

down

46.15

Over 1 Year

down

64.19

Over 3 Years

down

18.46

Over 5 Years

down

67.79

WELCURE DRUGS & PHARMACEUTICAL Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

WELCURE DRUGS & PHARMACEUTICAL Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
100.0
Promoter Holdings
0.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Vizwise Commerce Private Limited Public Shareholding 302217.0 2.24
Shubham Garg Public Shareholding 257700.0 1.91
Vinod K S Public Shareholding 202250.0 1.5
Dharam Chand Jain Shareholding of Promoter and Promoter Group 0.0 0.0

WELCURE DRUGS & PHARMACEUTICAL

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About WELCURE DRUGS & PHARMACEUTICAL

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by WELCURE DRUGS & PHARMACEUTICAL

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Welcure Drugs & Pharmaceuticals Ltd?

Answer Field

The share price of Welcure Drugs & Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 6.66.

What is the Market Cap of Welcure Drugs & Pharmaceuticals Ltd?

Answer Field

The market cap of Welcure Drugs & Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 9.00 Cr. as of now.

What is the 52 Week High and Low of Welcure Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Welcure Drugs & Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 6.98 and ₹ 3.20.

How to Buy Welcure Drugs & Pharmaceuticals Ltd share?

Answer Field

You can trade in Welcure Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Welcure Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 64.19%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader